Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-linked terminal galactose residues are carbohydrate structures found at the distal ends of N-glycan chains on cell-surface and secreted glycoproteins. These residues are typically masked by terminal sialic acids; their exposure, often termed desialylation, serves as a key biological signal for protein turnover and cell-cell interactions (Stockert, 1995). The primary physiological receptor for these residues is the Ashwell-Morell receptor (asialoglycoprotein receptor, ASGPR) located on hepatocytes, which facilitates the endocytosis and degradation of desialylated proteins (Ashwell & Harford, 1982). In pathological contexts, such as cancer, aberrant glycosylation leads to the overexposure of terminal galactose, which can promote metastasis by interacting with galectins or facilitate immune evasion (Pinho & Reis, 2015). From a pharmacological perspective, terminal galactose residues are targeted for liver-specific drug delivery systems and are the binding targets for potent toxins like ricin, as well as various diagnostic lectins (Lord et al., 2003).
Binding to asialoglycoprotein receptors (ASGPR) for hepatic clearance, or interaction with galectins to modulate cell signaling and adhesion (Stockert, 1995; Johannes et al., 2018).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-linked terminal galactose residues on cell-surface glycans (Terminal Gal).